Medical Devices-Evidence and Research is a premier peer-reviewed open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of medical technology and device innovation. Launched in 2008 and headquartered in New Zealand, the journal focuses on the dissemination of high-quality research that evaluates the efficacy, safety, and usability of medical devices across various clinical applications. With an impact factor reflective of its established position in the field and currently classified in the Q3 quartile for both Biomedical Engineering and Miscellaneous Medicine categories, it serves as a vital resource for professionals, researchers, and students committed to enhancing healthcare outcomes through device research and development. The journal fosters collaboration and knowledge sharing among its global readership, making significant contributions to the understanding and implementation of innovative medical technologies. In addition, the open-access model ensures that high-impact research remains accessible to all, thereby supporting the ongoing education and development of the scientific community.

ANNALS OF BIOMEDICAL ENGINEERING is a premier journal in the field of biomedical engineering, published by Springer. Established in 1972, this journal has become a vital resource for researchers, professionals, and students engaged in the rapidly evolving domain of biomedical technology. With a commendable impact factor and ranked in the 76th percentile among its peers as per Scopus, it exemplifies excellence in disseminating critical research findings. The journal covers a broad scope of topics related to the integration of engineering principles with medical and biological sciences, facilitating innovations that enhance healthcare outcomes. Although open access is not offered in this journal, it remains an essential platform for scholarly communication, contributing to the continuous advancement of knowledge in biomedical engineering. ANNALS OF BIOMEDICAL ENGINEERING is not only a bridge for academics to share groundbreaking research but also an influential guide for practical applications in medicine and health technologies, making it a fundamental publication for its readership.

Photobiomodulation Photomedicine and Laser Surgery is a premier peer-reviewed journal published by MARY ANN LIEBERT, INC, dedicated to advancing the understanding of light-based therapies in biomedical applications. With an impressive impact factor, this journal occupies a significant position in the field of Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, evidenced by its placement in the Q3 category for both fields as of 2023. The journal's scope encompasses a wide array of research topics, including but not limited to, the therapeutic effects of photobiomodulation and innovative laser surgical techniques. Researchers and practitioners alike can benefit from its open-access format, facilitating the dissemination of cutting-edge findings to a global audience. By bridging the gap between scientific inquiry and clinical application, Photobiomodulation Photomedicine and Laser Surgery plays a crucial role in fostering the integration of advanced technologies in healthcare, enhancing patient outcomes and pushing the boundaries of medical science.

REVISTA CLINICA ESPANOLA, a leading journal in the field of general medicine, has been a pivotal platform for disseminating clinical research and advancements since its inception in 1947. Published by EDICIONES DOYMA S A in Barcelona, Spain, this journal plays a significant role in enhancing medical practice and research, as evidenced by its impressive Scopus ranking of #116 out of 636 in the field, placing it in the 81st percentile. Although it currently does not offer open access options, the journal continues to attract high-quality submissions focused on diverse medical topics, making it an essential resource for health professionals, researchers, and students alike. With a current categorization of Q3 in Medicine (miscellaneous), REVISTA CLINICA ESPANOLA remains committed to bridging the gap between clinical practice and research, thereby contributing to the overall improvement of healthcare outcomes.

IRBM, published by Elsevier Science Inc, stands at the forefront of research in the domains of Biomedical Engineering and Biophysics, boasting impressively high rankings with a Q1 category in both fields according to the 2023 evaluations. With an effective focus on cutting-edge innovations and methodologies, IRBM provides a vital platform for researchers, professionals, and students alike seeking to disseminate and access groundbreaking findings and developments. Its strong presence in the Scopus database, with ranks of #12 in Biochemistry, Genetics and Molecular Biology and #42 in Biomedical Engineering, places it in the top percentile of impactful journals in the field, making it a crucial resource for advancing knowledge and fostering collaboration. While the journal maintains a traditional subscription model, it continues to attract a diverse readership eager for insightful studies and reviews that push the boundaries of science and engineering. With a projected convergence of years extending to 2024, IRBM promises to remain a significant contributor to the ongoing dialogue in the life sciences.

The International Journal of Biomedical Engineering and Technology, published by INDERSCIENCE ENTERPRISES LTD, serves as a pivotal platform for the dissemination of innovative research in the field of biomedical engineering. This journal, with ISSN 1752-6418 and E-ISSN 1752-6426, has been a valuable resource since its inception in 2007, boasting a converged publication timeline extending to 2024. Based in the United Kingdom, the journal aims to bridge the gap between engineering and biomedical sciences, facilitating interdisciplinary collaboration. As reflected in its 2023 Scopus ranking in the Q4 quartile of Biomedical Engineering, the journal remains accessible for researchers at various stages of their careers, contributing to its significance in promoting advancements in healthcare technologies. While currently not an open-access publication, the journal remains dedicated to enriching the biomedical engineering community by presenting novel research that addresses critical challenges, ultimately aiming to improve patient outcomes and drive innovation in medical devices and therapies.

Welcome to the Journal of Taibah University Medical Sciences, a distinguished open-access publication dedicated to advancing knowledge in the field of medicine. Since its inception in 2006, and published by ELSEVIER, this journal has become a vital resource for researchers and healthcare professionals alike, reflecting a steadfast commitment to disseminating innovative research and high-quality medical studies. With an impressive impact factor and a Scopus ranking placing it in the top 25% of general medicine journals, this publication occupies a notable position in the academic landscape. The journal covers a wide array of topics within the medical sciences, from clinical research to public health initiatives. As a Q3 category journal in the 2023 rankings, it continues to attract submissions that contribute meaningfully to the diverse and evolving field of medicine, supporting an open-access model that ensures widespread accessibility to its invaluable content. Explore the Journal of Taibah University Medical Sciences to stay abreast of the latest scientific advancements and engage with fellow scholars across the globe.

Tzu Chi Medical Journal, published by Wolters Kluwer Medknow Publications, is a prominent open-access journal that has been serving the medical community since its inception in 1997. With an ISSN of 1016-3190 and an E-ISSN of 2223-8956, this journal is dedicated to disseminating valuable research across various domains of medicine, achieving a prestigious Q3 ranking in the Medicine (miscellaneous) category for 2023. Operating under an open-access model since 2017, it ensures that research is freely accessible to a global audience, fostering collaboration and innovation in healthcare. Tzu Chi Medical Journal is recognized for its quality contributions, ranked #152 out of 636 in the general medicine category on Scopus, placing it in the top 25% of journals in this field. Based in Mumbai, India, it serves as an essential platform for researchers, healthcare professionals, and students aiming to share and engage with groundbreaking work in medicine, thus driving the field forward.

Journal of Pediatric and Neonatal Individualized Medicine, published by HYGEIA PRESS CORRIDORI MARINELLA in Italy, is a premier open-access journal committed to advancing the field of pediatrics and neonatal care. With its ISSN 2281-0692, this journal has been providing a platform for the dissemination of innovative research and practices since its establishment in 2012. Positioned in the Q3 category for 2023 in Pediatrics, Perinatology and Child Health, it serves a crucial role in enhancing knowledge and fostering collaboration among researchers, practitioners, and students. Although it currently holds a Scopus rank of 226/330, representing the 31st percentile, the journal aims to elevate its impact by publishing high-quality, peer-reviewed articles that focus on individualized medicine approaches for pediatric and neonatal patients. By making research openly accessible, the journal not only supports a wide readership but also encourages ongoing dialogue and innovation in pediatric healthcare practices.

Minerva Urology and Nephrology is a prestigious journal published by EDIZIONI MINERVA MEDICA, focusing on the rapidly evolving fields of urology and nephrology. Since its inception in 2021, this journal has established itself as a leading platform for innovative research, evidenced by its impressive Q1 quartile ranking in both nephrology and urology for the year 2023. With an ISSN of 2724-6051 and an E-ISSN of 2724-6442, it provides a rigorous peer-review process and publishes cutting-edge studies that push the boundaries of current understanding and clinical practice. Although currently not open access, Minerva Urology and Nephrology aims to facilitate knowledge sharing among researchers, healthcare professionals, and students who are engaged in these critical areas of medicine. This journal’s commitment to quality and relevance positions it as an essential resource for anyone interested in advancing their knowledge and skills in urology and nephrology.